Natriuretic Peptide, Brain: Clinical Trials

4 trials for Natriuretic Peptide, Brain, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 unknown. 1 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 41Recruiting 1

Follow Natriuretic Peptide, Brain: new trials by email Literature Review of Natriuretic Peptide, Brain trials Research Report on Natriuretic Peptide, Brain

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Undergoing Valve Surgery.
Losartan 50 mg, Placebo - Heart Valve Diseases, Left Ventricle Remodeling
Phase 4RecruitingVitor Emer Egypto Rosa602025-07-012025-08-01
BNP and Vascular Surgery
General Anesthesia, Vascular Surgery
UnknownUniversity of Parma1652018-12-102019-04-24
Effect of Sodium Intake on Brain Natriuretic Peptide Levels in Patients With Heart Failure
Severe sodium restriction, Moderate sodium restriction - Diet, Sodium-Restricted, Heart Failure, Systolic
Not applicableCompletedInstituto Mexicano del Seguro Social702017-11-222020-09-09
Myocardial Injury is Not Related to Training Levels Among Recreational Participants in the Silicon Valley Marathon
Troponin, Natriuretic Peptide, Brain
CompletedStanford University532006-01-012007-11-19

Narrower conditions

Aortic Aneurysm, Abdominal (1)  ·  Aortic Valve Insufficiency (1)  ·  Heart Failure (1)  ·  Heart Failure, Systolic (1)  ·  Heart Valve Diseases (1)  ·  Motor Activity (1)  ·  Ventricular Remodeling (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Heart Diseases (2)  ·  Aneurysm (1)  ·  Aortic Aneurysm (1)  ·  Aortic Diseases (1)  ·  Aortic Valve Disease (1)  ·  Behavior (1)  ·  Heart Failure (1)  ·  Pathological Conditions, Anatomical (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Vascular Diseases (1)

Interventions

Losartan (1)

Sponsors

Instituto Mexicano del Seguro Social (1)  ·  Stanford University (1)  ·  University of Parma (1)  ·  Vitor Emer Egypto Rosa (1)

Countries

Brazil (1)  ·  Italy (1)  ·  Mexico (1)

Top investigators

Juan B Ivey-Miranda, MD (1)  ·  Suzanne M Miller, MD (1)  ·  Vitor E. E. Rosa, MD, PhD (1)

Results publications

PMID 34490604

NIH funding

2023 (1)